Ultrasound energy (UltraShape). This type of treatment uses ultrasound energy to break down fat. It is the most time-intensive of the four types, taking approximately one hour per treatment session. Instead of hooking you up to a machine, a technician will move the device around manually. It uses a mechanical vibration to break down and destroy fat. This works on the abdomen and isn’t meant for other areas, Dr. Khetarpal says. There is no discomfort, she says.
During opening week, Friend #1 was our pioneer in testing out the gym. On his much anticipated return, his report was not entirely satisfactory. "It's quite good, but it does have the feel of a correctional facility." Not a great account, but I remained hopeful. Perhaps this merely revealed more about Friend #1's chequered past rather than the quality of Pure Gym.
Other factors that can affect the treatment include your budget. Some treatments are more expensive than others. Body sculpting treatments without surgery is much more cost effective than traditional surgeries. Your skin condition will also effect how the treatment is conducted. If you have skin allergies, the treatment method will vary accordingly. Your doctor’s recommendation will be a crucial factor on how the treatment sessions are carried out.
For Marco Polo Club members of any level residing in Hong Kong, the partnership means they will now be able to get a complimentary 10-day pass to all Pure gym locations for first-time visitors, as well as a 50 per cent discount on any joining fee thereafter, five personal training sessions (at a cost of HK$3,250), and 25 per cent off of food juice cleanses.

Fodor is more enthusiastic about the LipoSonix technology. "I am very optimistic," he says." I love the results," he says citing as much as a 7-centimeter reduction in waist circumference seen in clinical trials conducted in Mexico. This technology, which uses high-intensity ultrasound waves, beamed about an inch under the skin to break up fatty tissue, has been studied in both pig models and in 33 people in Mexico, he says. The company has applied for FDA status to begin preclinical studies in the U.S. and expects such trials to begin in 2007.
1 July 2015: The CMA is considering whether it is or may be the case that this transaction has resulted in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that situation has resulted, or may be expected to result, in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services.
×